In what can be called as the news that hits the positive vibes amidst the corona chaos, Pune-based Serum Institute, the world’s largest vaccine manufacturer announced that it is working towards delivering of up to 100 million doses of Covid-19 vaccines to India as soon as possible.
Snubbing aside the rumours that the vaccine would a costly affair making it difficult for the middle and below middle-class people to afford, the company stated that it has set an affordable ceiling price of $3 (around Rs 225) per dose. The vaccine is expected to be ready by 2021 in India and other low-income countries.
Further, the company said that their new partnership with international vaccine alliance Gavi and Bill & Melinda Gates Foundation has even the confidence to deliver the vaccine in a larger extent at affordable prices.
“In an attempt to make our fight against COVID-19 stronger and all-embracing; SII has partnered with Gavi and the Bill & Melinda Gates Foundation to advance the manufacturing and delivery of up to 100 million doses of future COVID vaccines for low and middle-income countries in 2021,” stated Adar Poonawalla, CEO of SII.
However, the company stated that the ceiling price is only for vaccines proposed to be distributed to 92 countries under the Covax alliance. The company also has prepared a framework which prioritizes healthcare professionals and frontline & other essentials workers and citizen over 65 years for distributing the doses.